Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
NurExone Biologic: Technisches (täglich, wöchentlich, monatlich) & Analysten "Strong Buy"-Rating!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DWEJ | ISIN: US15117N6022 | Ticker-Symbol: CBO
Tradegate
28.03.24
16:06 Uhr
1,430 Euro
-0,260
-15,38 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMUNON INC Chart 1 Jahr
5-Tage-Chart
IMUNON INC 5-Tage-Chart
RealtimeGeldBriefZeit
1,4301,61028.03.
1,6301,74028.03.

Aktuelle News zur IMUNON Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoImunon Inc reports results for the quarter ended in December - Earnings Summary2
DoImunon GAAP EPS of -$2.16 beats by $0.071
DoImunon, Inc. - 10-K, Annual Report1
DoImunon, Inc. - 8-K, Current Report-
MiPreview: Imunon's Earnings1
MiImunon FY Earnings Preview1
DiImunon Inc expected to post a loss of 41 cents a share - Earnings Preview4
MoIMUNON secures $1.3 million through NOL sale1
MoIMUNON receives $1.3M from sale of its New Jersey net operating losses1
MoImunon, Inc.: IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses1
21.03.Imunon, Inc.: IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 20241
12.03.IMUNON announces CEO resignation2
12.03.Imunon, Inc.: IMUNON Announces Leadership Change1.416Executive Chairman to lead day-to-day operations, active search underway for CEO successor.Timing of upcoming milestones for key programs remains unchanged. LAWRENCEVILLE, N.J., March 12, 2024 (GLOBE...
► Artikel lesen
12.03.Imunon, Inc. - 8-K, Current Report1
29.02.IMUNON stock rallies 19% on early results for COVID-19 vaccine2
29.02.IMUNON reports promising vaccine study results1
29.02.Imunon, Inc.: Independent Lab Confirms Immunogenicity and Protection with IMUNON's IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5143Murine Study by the Wistar Institute Builds Upon Favorable Results Previously Reported by IMUNON With its Prototype PlaCCine Vaccine Modality LAWRENCEVILLE, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
29.12.23Imunon, Inc. - 8-K, Current Report3
21.12.23Imunon files to sell ordinary shares, warrants5
20.12.23Imunon, Inc. - S-1, General form for registration of securities3
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2